Evidence map›Paper›PMID 32049134›Full record

ArticleJournal of applied oral science : revista FOB2020

Effect of focal adhesion kinase inhibition on osteoblastic cells grown on titanium with different topographies.

Helena Bacha Lopes, Alann Thaffarell Portilho Souza, Gileade Pereira Freitas, Carlos Nelson Elias, Adalberto Luiz Rosa, Marcio Mateus Beloti

Open access · diamondAbstract read
In one paragraph

Article in Journal of applied oral science : revista FOB, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Helena Bacha LopesUniversidade de São Paulo, Faculdade de Odontologia de Ribeirão Preto, Bone Research Laboratory, Ribeirão Preto, São Paulo, Brasil.ORCID http://orcid.org/0000-0002-6998-5296
Alann Thaffarell Portilho SouzaUniversidade de São Paulo, Faculdade de Odontologia de Ribeirão Preto, Bone Research Laboratory, Ribeirão Preto, São Paulo, Brasil.ORCID http://orcid.org/0000-0001-7344-5420
Gileade Pereira FreitasUniversidade de São Paulo, Faculdade de Odontologia de Ribeirão Preto, Bone Research Laboratory, Ribeirão Preto, São Paulo, Brasil.ORCID http://orcid.org/0000-0002-1674-4667
Carlos Nelson EliasInstituto Militar de Engenharia, Laboratório de Biomateriais, Rio de Janeiro, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0002-7560-6926
Adalberto Luiz RosaUniversidade de São Paulo, Faculdade de Odontologia de Ribeirão Preto, Bone Research Laboratory, Ribeirão Preto, São Paulo, Brasil.ORCID http://orcid.org/0000-0002-6495-2778
Marcio Mateus BelotiUniversidade de São Paulo, Faculdade de Odontologia de Ribeirão Preto, Bone Research Laboratory, Ribeirão Preto, São Paulo, Brasil.ORCID http://orcid.org/0000-0003-0149-7189
Universidade de São Paulo · BRMilitary Institute of Engineering · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe present study aimed to investigate the participation of focal adhesion kinases (FAK) in interactions between osteoblastic cells and titanium (Ti) surfaces with three different topographies, namely, untreated (US), microstructured (MS), and nanostructured (NS). METHODOLOGY: Osteoblasts harvested from the calvarial bones of 3-day-old rats were cultured on US, MS and NS discs in the presence of PF-573228 (FAK inhibitor) to evaluate osteoblastic differentiation. After 24 h, we evaluated osteoblast morphology and vinculin expression, and on day 10, the following parameters: gene expression of osteoblastic markers and integrin signaling components, FAK protein expression and alkaline phosphatase (ALP) activity. A smooth surface, porosities at the microscale level, and nanocavities were observed in US, MS, and NS, respectively.

resultsFAK inhibition decreased the number of filopodia in cells grown on US and MS compared with that in NS. FAK inhibition decreased the gene expression of Alp, bone sialoprotein, osteocalcin, and ALP activity in cells grown on all evaluated surfaces. FAK inhibition did not affect the gene expression of Fak, integrin alpha 1 ( Itga1 ) and integrin beta 1 ( Itgb1 ) in cells grown on MS, increased the gene expression of Fak in cells grown on NS, and increased the gene expression of Itga1 and Itgb1 in cells grown on US and NS. Moreover, FAK protein expression decreased in cells cultured on US but increased in cells cultured on MS and NS after FAK inhibition; no difference in the expression of vinculin was observed among cells grown on all surfaces.

conclusionsOur data demonstrate the relevance of FAK in the interactions between osteoblastic cells and Ti surfaces regardless of surface topography. Nanotopography positively regulated FAK expression and integrin signaling pathway components during osteoblast differentiation. In this context, the development of Ti surfaces with the ability to upregulate FAK activity could positively impact the process of implant osseointegration.

Indexed as

AnimalsCell DifferentiationCell ProliferationCells, CulturedFocal Adhesion Protein-Tyrosine KinasesGene ExpressionIntegrinsMicroscopy, Electron, ScanningOsseointegrationOsteoblastsQuinolonesRats, WistarReal-Time Polymerase Chain ReactionSignal TransductionSulfonesSurface Properties6-(4-(3-(methylsulfonyl)benzylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-3,4-dihydroquinolin-2(1H)-oneFocal Adhesion Protein-Tyrosine KinasesIntegrinsQuinolonesSulfonesTitanium

Identifiers

PMID32049134
PMCPMC6999121
OpenAlexW3004977447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.